NCT01947920View on ClinicalTrials.gov

A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

Tramadol HCl, 50 mg

50-mg overencapsulated tablet for oral administration

DRUG

Placebo

Size-matching capsules containing an appropriate inactive excipient

Trial Locations (1)

Unknown

Overland Park

Sponsors
All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

collaborator

Cipher Pharmaceuticals Inc.

INDUSTRY

lead

Janssen Scientific Affairs, LLC

INDUSTRY